Binding of drugs to serum albumin (first of two parts).

Interactive association of drugs binding to human serum albumin.

Comparison of binding characterization of two antiviral drugs to human serum albumin.

Histamine (first of two parts).

Binding of the membrane active drugs to bovine serum albumin and human erythrocyte membranes.

Myasthenia gravis (first of two parts).

Renal transplantation (first of two parts).

Lung defense mechanisms (first of two parts).

Polymyositis and dermatomyositis (first of two parts).

ATP binding to bovine serum albumin.

Thermodynamic analysis of thymoquinone binding to human serum albumin.

The binding of palmitoyl-CoA to bovine serum albumin.

Photoactivated covalent binding of [3H]bilirubin to human serum albumin.

Binding of porphyrin to human serum albumin. Structure-activity relationships.

Stereoselective binding of etodolac to human serum albumin.

The binding of pyridoxal 5'-phosphate to human serum albumin.

Enzymology of cancer cells (first of two parts).

Clinical pharmacology of oral antidiabetic agents (first of two parts).

Germ-cell testicular cancer in adults (first of two parts).

Dialytic therapy for irreversible uremia (first of two parts).

Catecholamines and neurologic diseases (first of two parts).

Drug therapy. Clinical Pharmacokinetics (first of two parts).

Secretin, cholecystokinin and newer gastrointestinal hormones (first of two parts).

Nonosmolar factors affecting renal water excretion (first of two parts).

Phenylbutazone and ketoprofen binding to serum albumin. Fluorescence study.

Suggest Documents

Interactive association of drugs binding to human serum albumin.

Comparison of binding characterization of two antiviral drugs to human serum albumin.

Histamine (first of two parts).

Binding of the membrane active drugs to bovine serum albumin and human erythrocyte membranes.

Myasthenia gravis (first of two parts).

Renal transplantation (first of two parts).

Lung defense mechanisms (first of two parts).

Polymyositis and dermatomyositis (first of two parts).

ATP binding to bovine serum albumin.

Thermodynamic analysis of thymoquinone binding to human serum albumin.

The binding of palmitoyl-CoA to bovine serum albumin.

Photoactivated covalent binding of [3H]bilirubin to human serum albumin.

Binding of porphyrin to human serum albumin. Structure-activity relationships.

Stereoselective binding of etodolac to human serum albumin.

The binding of pyridoxal 5'-phosphate to human serum albumin.

Enzymology of cancer cells (first of two parts).

Clinical pharmacology of oral antidiabetic agents (first of two parts).

Germ-cell testicular cancer in adults (first of two parts).

Dialytic therapy for irreversible uremia (first of two parts).

Catecholamines and neurologic diseases (first of two parts).

Drug therapy. Clinical Pharmacokinetics (first of two parts).

Secretin, cholecystokinin and newer gastrointestinal hormones (first of two parts).

Nonosmolar factors affecting renal water excretion (first of two parts).

Phenylbutazone and ketoprofen binding to serum albumin. Fluorescence study.

Binding of drugs to serum albumin (first of two parts).

Recommend Documents

Follow Us